Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient

Shiv Gandhi; Sukanya Narasimhan; Aster Workineh; Mark Mamula; Jennifer Yoon; Peter J Krause; Shelli F Farhadian

doi:10.1093/ofid/ofac295

Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient

Open Forum Infect Dis. 2022 Jun 13;9(7):ofac295. doi: 10.1093/ofid/ofac295. eCollection 2022 Jul.

Authors

Shiv Gandhi¹, Sukanya Narasimhan¹, Aster Workineh¹, Mark Mamula², Jennifer Yoon¹, Peter J Krause³, Shelli F Farhadian¹

Affiliations

¹ Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
² Section of Rheumatology, Yale School of Medicine, New Haven, Connecticut, USA.
³ Department of Epidemiology of Microbial Diseases, Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, USA.

Abstract

Borrelia miyamotoi is an underdiagnosed cause of tick-borne illness in endemic regions and, in rare cases, causes neurological disease in immunocompetent patients. Here, we present a case of serologically confirmed Borrelia miyamotoi meningoencephalitis in an otherwise healthy patient who rapidly improved following initiation of antibiotic therapy.

Keywords: Borrelia; meningoencephalitis; miyamotoi.

Publication types

Case Reports

Abstract

Publication types

Grants and funding